Ahead of its full-year results on May 26, woundcare house Aroa Biosurgery says it will exceed its revenue and earnings ...

The World Health Organization (WHO) has validated Australia for eliminating trachoma as a public health problem, marking a ...

Residents and schools near the proposed Western Sydney site of what would be Australia’s most power-hungry data centre have ...

Frontline workers have warned Australians are already facing severe consequences of the escalating affordability crisis.

A tax on sugary drinks and a sweeping overhaul of Australia’s health system have been put squarely on the federal budget ...

The proposed Atlas Arteria takeover is the third-biggest merger and acquisition announced this year, pushing the investment ...

Another ASX 200 share worth looking at in May is CAR Group. CAR Group owns digital vehicle marketplaces across Australia and ...

A new Australian study has found children who demonstrate stronger pretend play skills at ages two and three are less likely ...

Most vision loss is preventable, yet many New Zealanders can’t afford care. Following Australia’s public funding model could ...

Entropy Neurodynamics and LTR Pharma among ASX health companies reporting clinical milestones reached in quarterly results.

Parents of gender-distressed adolescents have accused Australia’s human rights commission president of “astounding arrogance” ...